# LIDOCAINE HYDROCHLORIDE
> **ANDA215132** · Abbreviated New Drug Application (Generic) · Sponsor: AFAXYS · Approved 2022-06-09
## Drug
- **FDA Application Number:** ANDA215132
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LIDOCAINE HYDROCHLORIDE
- **Generic name:** LIDOCAINE HYDROCHLORIDE
- **Active ingredients:** LIDOCAINE HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** AFAXYS
- **Manufacturer:** Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- **First approval:** 2022-06-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215132)
---
*AI Analytics · CC0 1.0*